Tag results:
reporter assay
Cancer Stem Cell News
MiR-342-3p Inhibits LCSC Oncogenicity and Cell Stemness through HDAC7/PTEN Axis
[Inflammation Research] miR-342-3p overexpression in LCSC lead to lower tumor volume, reduced tumor spheroid formation and agar colony formation rates, as well as lower mRNA and protein expressions of CD44, ALDH1, Bmi1, Sox2, and Oct4.
Intestinal Cell News
Positive Feedback Loop of lncRNA SNHG1/miR-16-5p/GATA4 in the Regulation of Hypoxia/Reoxygenation-Induced Cardiomyocyte Injury
[Molecular Medicine Reports] The authors explored the role and molecular mechanism of lncRNA small nucleolar RNA host gene 1 (SNHG1) in ischemic cardiomyocyte injury.
Mesenchymal Cell News
Extracellular Vesicles Derived from Hypoxia-Preconditioned Olfactory Mucosa Mesenchymal Stem Cells Enhance Angiogenesis via miR-612
[Journal of Nanobiotechnology] Investigators explored the effects of extracellular vesicles from human hypoxic olfactory mucosa MSCs on angiogenesis and its underlying mechanism.
Prostate Cell News
Transcription Factor p53-Mediated Activation of miR-519d-3p and Downregulation of E2F1 Attenuates Prostate Cancer Growth and Metastasis
[Cancer Gene Therapy] Investigators uncovered that the transcription factor p53 could upregulate miR-519d-3p expression to directly suppress the expression of E2F transcription factor 1 (E2F1), thus inhibiting prostate cancer growth and metastasis.
Umbilical & Placental Cell News
MiR-455-5p Upregulation in Umbilical Cord Mesenchymal Stem Cells Attenuates Endometrial Injury and Promotes Repair of Damaged Endometrium via Janus Kinase/Signal Transducer and Activator of...
[Bioengineered] Scientists investigated the specific impacts of umbilical cord mesenchymal stem cells overexpressing miR-455-5p in intrauterine adhesions.
Neural Cell News
EGR1 Modulated LncRNA HNF1A-AS1 Drives Glioblastoma Progression via miR-22-3p/ENO1 Axis
[Cell Death Discovery] Accumulating evidence revealed that long noncoding RNAs (lncRNAs) have been participating in cancer malignant progression, including glioblastoma multiforme (GBM). Scientists illuminated the definite mechanism of HNF1A-AS1 in promoting GBM malignancy.